flavone has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeon, SB; Kim, G; Kim, IK; Kim, JI; Kim, SH; Lee, YH; Seok, YM; Shin, HM; Suk, K | 1 |
1 other study(ies) available for flavone and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Flavone inhibits vascular contraction by decreasing phosphorylation of the myosin phosphatase target subunit.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta, Thoracic; Dose-Response Relationship, Drug; Flavones; Flavonoids; In Vitro Techniques; Male; Myosin Light Chains; Phosphorylation; Protein Phosphatase 1; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Signal Transduction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2007 |